Lab
Medical Assay Laboratory
Medical Assay Laboratory was paid $5.47M by Medicaid between Jan 2018 and Dec 2024, across 59 billing codes. Its largest line is 87636, Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B — 31% of everything it billed.
33Billing provider infoMEDICAL ASSAY LABORATORY
WESTMONT, IL 60559
WESTMONT, IL 60559
33aNPI1760414221assigned 07/07/2006
33bProvider typeClinical Medical Laboratory
28Total paid$5.47M
24GClaims167,169
24DCodes billed59
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Illinois
Rank by total paid#34 of 235
Median peer was paid$123K
This provider vs. median45×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,357 | $55K | |
| 2019 | 8,204 | $64K | |
| 2020 | 6,894 | $64K | |
| 2021 | 13,708 | $311K | |
| 2022 | 61,408 | $1.91M | |
| 2023 | 46,568 | $2.08M | |
| 2024incomplete | 23,030 | $979K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 31% | 14,274 | 8,750 | $1.72M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 20% | 17,701 | 10,958 | $1.08M |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 12% | 5,951 | 4,039 | $678K |
| 87634 | 11% | 14,309 | 8,763 | $620K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 11% | 30,152 | 17,988 | $578K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 4.5% | 13,567 | 8,791 | $244K |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 2.1% | 5,385 | 2,573 | $114K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,075 | 3,512 | $50K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 4,030 | 2,992 | $38K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,923 | 5,604 | $37K |
| 80053 | Comprehensive metabolic panel | <1% | 4,505 | 3,553 | $32K |
| 82607 | <1% | 2,727 | 2,067 | $25K |
47 more codes
| 83970 | <1% | 931 | $22K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,191 | $21K |
| 80061 | Lipid panel | <1% | 4,453 | $19K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 330 | $14K |
| 82747 | <1% | 1,248 | $14K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 46 | $13K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 118 | $13K |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 5,179 | $12K |
| 83735 | <1% | 1,875 | $9K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 314 | $9K |
| 84481 | <1% | 954 | $8K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,303 | $7K |
| 85610 | <1% | 2,246 | $7K | |
| 84100 | <1% | 2,091 | $6K | |
| 84479 | <1% | 1,241 | $6K | |
| 84436 | <1% | 1,105 | $6K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,726 | $6K |
| 87186 | <1% | 725 | $5K | |
| 84153 | <1% | 490 | $5K | |
| 87088 | <1% | 643 | $5K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 646 | $4K |
| 83550 | <1% | 533 | $3K | |
| 83540 | <1% | 632 | $3K | |
| 82728 | <1% | 483 | $3K | |
| 80076 | <1% | 515 | $3K | |
| 87500 | <1% | 119 | $3K | |
| 86480 | <1% | 59 | $2K | |
| 80050 | General health panel | <1% | 69 | $2K |
| 87147 | <1% | 773 | $2K | |
| 87210 | <1% | 536 | $2K | |
| 87590 | <1% | 80 | $2K | |
| 84550 | <1% | 536 | $2K | |
| 80184 | <1% | 242 | $2K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 61 | $2K |
| 87640 | <1% | 61 | $2K | |
| 81003 | <1% | 994 | $2K | |
| 87490 | <1% | 80 | $1K | |
| 85652 | <1% | 506 | $1K | |
| 87660 | <1% | 68 | $925.10 | |
| 87081 | <1% | 106 | $903.73 | |
| 87641 | <1% | 29 | $880.78 | |
| 87653 | <1% | 21 | $769.88 | |
| 80299 | <1% | 41 | $686.39 | |
| 87109 | <1% | 80 | $674.65 | |
| 87650 | <1% | 21 | $440.10 | |
| 80165 | <1% | 54 | $428.75 | |
| 86709 | <1% | 16 | $64.21 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCHALOKWU, CHRISTAPHER (ADMINISTRATOR)